Ftse Mib
34.127,62
-0,72%
DAX
19.906,08
-0,49%
S&P 500
5.942,47
1,26%
NASDAQ
19.621,68
1,77%
Bitcoin
98.361,49
0,15%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Apollomics Inc (APLMW) Apollomics Inc (APLMW) Notizie

Apollomics Inc

APLMW
0,009
-0,0003 (-3,23%)
03 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Warrant Azionario
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
20/12/202414:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/12/202422:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/11/202423:25EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/11/202421:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/8/202416:50APSBiotech Sees Massive Buying Pressure Following Phase 2..
04/6/202414:00GLOBEApollomics Announces Vebreltinib Data at the 2024 American..
30/5/202422:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
30/5/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
29/5/202423:12EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
29/5/202414:00GLOBEApollomics Announces Presentation at the 2024 BIO..
24/5/202423:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/5/202422:58EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
20/5/202422:32EDGAR2Form F-3 - Registration statement by foreign private issuers
20/5/202422:15EDGAR2Form SC 13G - Statement of acquisition of beneficial..
08/5/202422:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/5/202422:05GLOBEApollomics Announces Private Placement Financing and..
25/4/202414:30GLOBEApollomics Announces Approval of Vebreltinib in China as a..
10/4/202413:00GLOBEApollomics Presents Vebreltinib Data at the 2024 American..
02/4/202414:00GLOBEApollomics Announces Poster Presentations of Vebreltinib..
28/3/202412:00GLOBEApollomics Highlights Clinical Progress and Reports Full..
26/3/202413:00GLOBEApollomics to Announce Full Year 2023 Financial Results and..
04/3/202413:00GLOBEApollomics Appoints Matthew Plunkett, Ph.D. as Chief..
07/2/202413:00GLOBEApollomics to Present at the Oppenheimer 34th Annual..
19/1/202422:15GLOBEApollomics Receives Nasdaq Notification Regarding Minimum..
17/1/202422:30GLOBEApollomics to Participate in a Fireside Chat at the B. Riley..
Apertura: 0,0184 Min: 0,009 Max: 0,0184
Chiusura: 0,0093

La tua Cronologia

NASDAQ
APLMW
Apollomics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network